These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26763106)

  • 1. The pharmacokinetics of intravenous fenoldopam in healthy, awake cats.
    O'Neill KE; Labato MA; Court MH
    J Vet Pharmacol Ther; 2016 Apr; 39(2):202-4. PubMed ID: 26763106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary pharmacokinetics and cardiovascular effects of fenoldopam continuous rate infusion in six healthy dogs.
    Bloom CA; Labato MA; Hazarika S; Court MH
    J Vet Pharmacol Ther; 2012 Jun; 35(3):224-30. PubMed ID: 21732952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
    Taylor AA; Shepherd AM; Polvino W; Mangoo-Karim R; Ballard K; Sunthornyothin S; Luther RR; Pool JL
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):906-14. PubMed ID: 10509549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of fenoldopam in critically ill small animal patients with acute kidney injury: 28 dogs and 34 cats (2008-2012).
    Nielsen LK; Bracker K; Price LL
    J Vet Emerg Crit Care (San Antonio); 2015; 25(3):396-404. PubMed ID: 25854861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Fenoldopam Continuous Infusion on Glomerular Filtration Rate and Fractional Excretion of Sodium in Healthy Dogs.
    Kelly KL; Drobatz KJ; Foster JD
    J Vet Intern Med; 2016 Sep; 30(5):1655-1660. PubMed ID: 27452198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
    Taylor AA; Mangoo-Karim R; Ballard KD; Luther RR; Pool JL
    J Clin Pharmacol; 1999 May; 39(5):471-9. PubMed ID: 10234594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fenoldopam mesylate on central hemodynamics and renal flow in patients undergoing cardiac surgery: color Doppler echocardiographic evaluation.
    Meco M; Cirri S
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):58-62. PubMed ID: 19553140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.
    Brogden RN; Markham A
    Drugs; 1997 Oct; 54(4):634-50. PubMed ID: 9339965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure.
    Piltz JR; Stone RA; Boike S; Everitt DE; Shusterman NH; Audet P; Zariffa N; Jorkasky DK
    J Ocul Pharmacol Ther; 1998 Jun; 14(3):203-16. PubMed ID: 9671428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fenoldopam mesylate on systemic hemodynamics and indices of renal function in normotensive neonatal foals.
    Hollis AR; Ousey JC; Palmer L; Stoneham SJ; Corley KT
    J Vet Intern Med; 2006; 20(3):595-600. PubMed ID: 16734095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data.
    Sorbello M; Morello G; Paratore A; Cutuli M; Mistretta G; Belluoccio AA; Veroux M; Veroux P; Macarone M; Gagliano M; Mangianeli S
    Transplant Proc; 2007; 39(6):1794-6. PubMed ID: 17692615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenoldopam for controlled hypotension during spinal fusion in children and adolescents.
    Tobias JD
    Paediatr Anaesth; 2000; 10(3):261-6. PubMed ID: 10792741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.
    Weber RR; McCoy CE; Ziemniak JA; Frederickson ED; Goldberg LI; Murphy MB
    Br J Clin Pharmacol; 1988 Jan; 25(1):17-21. PubMed ID: 2897206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.
    Roasio A; Lobreglio R; Santin A; Landoni G; Verdecchia C
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):23-6. PubMed ID: 18249326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of fenoldopam mesylate in preventing peak blood lactate level during cardiopulmonary bypass for paediatric cardiac surgery.
    Ressia L; Calevo MG; Lerzo F; Carleo AM; Petrucci L; Montobbio G
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):178-82. PubMed ID: 24771205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
    Fontana I; Germi MR; Beatini M; Fontana S; Bertocchi M; Porcile E; Saltalamacchia L; Ornis S; Ghinolfi D; Bonifazio L; Valente U
    Transplant Proc; 2005; 37(6):2474-5. PubMed ID: 16182714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.
    Talati S; Kirtane AJ; Hassanin A; Mehran R; Leon MB; Moses JW; Weisz G
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):506-9. PubMed ID: 22469256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.
    Tumlin JA; Dunbar LM; Oparil S; Buckalew V; Ram CV; Mathur V; Ellis D; McGuire D; Fellmann J; Luther RR
    Acad Emerg Med; 2000 Jun; 7(6):653-62. PubMed ID: 10905644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.